Close

Aethlon Medical Announces Collaboration With Prostate On-Site Project (POP), Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies May 13, 2019 08:00AM
Aethlon Medical (AEMD) Announces Timothy Rodell as Interim CEO Dec 13, 2018 08:32AM
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer Dec 13, 2018 08:29AM
Aethlon Medical (AEMD) Receives FDA 'Breakthrough Device' Designation for Hemopurifier Nov 27, 2018 07:59AM
Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration Nov 27, 2018 07:21AM
View Older Stories

Nov 6, 2018 04:15PM Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results
Nov 1, 2018 08:30AM Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018
Oct 29, 2018 11:59AM Aethlon Medical to Present at the NYC Oncology Conference
Oct 16, 2018 08:15AM Aethlon Medical to Present at the 2018 BIO Investor Forum
Sep 18, 2018 08:46AM Aethlon Medical Receives National Cancer Institute Award
Aug 8, 2018 04:15PM Aethlon Medical Announces First Quarter Fiscal Year 2019 Results
Aug 2, 2018 08:15AM Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018
Jul 23, 2018 08:15AM Aethlon Medical Announces Issuance of Hemopurifier® Patent To Treat Life-Threatening Viruses
Jun 25, 2018 09:16AM Aethlon Medical (AEMD) Names Joins Aethlon to Board of Directors
Jun 25, 2018 09:15AM Guy Cipriani Joins Aethlon Medical's Board of Directors
Jun 8, 2018 04:15PM Aethlon Medical Announces Fiscal 2018 Results
May 31, 2018 08:45AM Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018
Mar 22, 2018 08:00AM Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix
Feb 12, 2018 06:32AM Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting
Feb 1, 2018 04:15PM Aethlon Medical Announces Fiscal 2018 Third Quarter Results
Jan 29, 2018 08:15AM Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018
Jan 23, 2018 08:16AM Aethlon Medical (AEMD) Reports Validation Completion for European Patent Protecting Methods of Quantifying Exosomes
Jan 23, 2018 08:15AM Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes
Jan 18, 2018 07:50AM Aethlon Medical (AEMD) Receives Patent that Broadens Protection for Hemopurifier to Treat Viral Infections
Jan 18, 2018 07:49AM Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections
Jan 10, 2018 09:08AM Aethlon Medical (AEMD) Appoints Sabrina Martucci Johnson to Board
Jan 10, 2018 09:01AM Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors
Nov 29, 2017 07:46AM Aethlon Medical (AEMD) Appoints Dr. Charles J. Fisher as Board Chairman
Nov 29, 2017 07:45AM Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Nov 9, 2017 01:03PM Aethlon Medical (AEMD) Appoints Dr. Charles J. Fisher, Jr. to Board
Nov 9, 2017 12:58PM Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors
Nov 2, 2017 04:15PM Aethlon Medical Announces Fiscal 2018 Second Quarter Results
Oct 30, 2017 07:30AM Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017
Oct 16, 2017 07:17AM Aethlon Medical (AEMD) Announces Production Collaboration with iBio, Inc. (IBIO)
Oct 16, 2017 07:15AM Aethlon Medical Announces Large-Scale Production Collaboration
Oct 16, 2017 07:15AM iBio Announces Manufacturing Collaboration with Aethlon Medical
Oct 11, 2017 08:15AM Aethlon Medical to Present at the 2017 BIO Investor Forum
Oct 10, 2017 01:28PM Aethlon Medical Announces Compliance With Nasdaq Listing Criteria
Oct 2, 2017 06:02AM Aethlon Medical (AEMD) Prices 5.45M Share Offering at $1.10/Sh
Oct 2, 2017 06:00AM Aethlon Medical Announces Pricing of $6 Million Public Offering
Sep 14, 2017 07:30AM Aethlon Medical Receives National Cancer Institute Contract Award
Sep 12, 2017 07:33AM Aethlon Medical (AEMD) Receives FDA Expedited Access Pathway Designation to Accelerate Access to Hemopurifier as Treatment for Life-Threatening Viruses
Sep 12, 2017 07:30AM Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses
Sep 6, 2017 09:12AM Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017
Aug 10, 2017 04:15PM Aethlon Medical Announces Fiscal 2018 First Quarter Results
Aug 3, 2017 08:00AM Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017
Jul 19, 2017 07:12AM Aethlon Medical (AEMD) Granted U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes
Jul 19, 2017 07:11AM Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes
Jun 28, 2017 04:15PM Aethlon Medical Announces Fiscal 2017 Results
Jun 26, 2017 08:15AM Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017
Jun 14, 2017 08:00AM Aethlon Medical To Present Clinical Study Results at The BIO International Convention
Jun 6, 2017 08:00AM Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017
May 24, 2017 08:00AM Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017
Apr 24, 2017 09:25AM Aethlon Medical Releases Shareholder Update
Apr 4, 2017 09:03AM Aethlon Medical Discloses Tech Nation Interview On National Public Radio
View Older Stories